IceCure Medical wins Chinese patent for cryogenic system connector
ICCM•IceCure Medical received a Chinese patent for a connector used in its cryogenic technology platform, bringing its intellectual property portfolio to 42 patents across the U.S., Europe and Asia.
1. Patent and portfolio
IceCure Medical received a Chinese patent covering a connector used in its cryogenic technology platform. The company’s intellectual property portfolio contains 42 patents across the U.S., Europe and Asia; the patent follows China’s September 2026 authorization to market the ProSense tumor-freezing system and associated cryoprobes.
